Asia-Pacific Clinical Practice Guidelines for the Management of Frailty
- Frailty is characterized by a ‘reduced strength and physiologic malfunctioning that increases an individual’s susceptibility to increased dependency, vulnerability, and death’, making it a major public health problem in the geriatric population
- Due to the lack of guidelines in the treatment of frailty, a group of experts has recently consolidated and developed a set of evidence-based, multidisciplinary Clinical Practice Guidelines (CPGs) for the identification and management of frailty for health practitioners in the Asia-Pacific region
The recommendations provided herein are intended for use by healthcare providers in their managements of older adults with frailty in the Asia Pacific region.
Seven key recommendation areas:
Strongly recommend |
1. Use of a validated measurement tool to identify frailty, such as using the Comprehensive Geriatric Assessment (CGA)
|
---|---|
2. Referral of older adults with frailty to a progress, individualized physical activity program with a resistance training components
|
|
3. Reduction of any inappropriate/superfluous medications
|
|
Conditionally recommend |
4. Screening for reversible causes of fatigue in persons with frailty
|
5. Screening,for reversible causes and consideration for protein and caloric supplementation in older adults with frailty who exhibit unintentional weight loss
|
|
6. Prescription of vitamin D for older adults who are deficient in vitamin D
|
|
No recommendation | 7. Provision of an individualized support and education plan for older adults with frailty |
Important note:
- Health practitioners should select the most appropriate interventions outlined in this CPGs, which are consistent with patient’s frailty stage, preference and feasibility
Reference
Dent E, et al. The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty. JAMDA. 2017;18:564-675.
Link to full publication: http://www.jamda.com/article/S1525-8610(17)30241-4/fulltext